- 360 WallStreet
- Posts
- Will Virgin Orbit Rocket Today?
Will Virgin Orbit Rocket Today?
Plus Billionaire Steve Cohen likes this small cap
*Together with
Good day, 360 –
Here are our TOP investing ideas today - be the best prepared trader on the Street!
VORB - Up over 20% in pre-market after reports company is working on an emergency $31M cash injection
ESPR - Trades 15% higher in premarket after Steve Cohen’s Point 72 Asset Management reports 5% passive stake in the company
MCOM - Up over 20% as the company announces it has identified consistent imbalances and reported short interest, signaling the potential presence of illegal naked short sales
*A Message on Behalf of Mainz Biomed
🔥 Hot Stock of the Day 🔥
Being the “first to market” comes with a lot of risks, but the rewards can be huge. Being “second to market” is a much smoother path, and can still yield incredible results.
That brings us to today’s new idea – Mainz Biomed (Nasdaq: MYNZ).
There are a few things that are great about this stock right now…
👉 MYNZ is attacking a market for testing kits where the only competitor has a monopoly with over $1 billion in sales so far.
Yeah, that annoying commercial on TV with this little guy has made well over $1 billion… and MYNZ is coming after them!
👉 The average analyst price target for MYNZ is over 218% higher than current levels (2 analysts reiterated their targets last week as you can see in the chart below):
MYNZ already has its product available in Europe and is currently enrolling people for its study in the US. They expect to have results very soon, sometime in the next few months. 🤞
MYNZ is one of those overlooked opportunities that is really worth your attention right now.
So, go do your homework on it right now while it is still at this price!
*Sponsored by Awareness Consulting Group, please see disclosures below.
VORB - Up over 20% in pre-market after reports company is working on an emergency $31M cash injection
Virgin Orbit Communications (VORB) are up over 20% in pre-market trade after a report from the Telegraph suggested the company is working with lawyers to agree on an emergency cash injection of around $31 million.
Telegraph reporter Matt Field tweeted, "On The Bankruptcy Call Now, Virgin Orbit And Its Lawyers Are Trying To Agree An Emergency Cash Injection, Or Debtor In Possession Financing, Of Around $31M, With The Court.”
The stock closed up over 34% yesterday after the news hit late afternoon and is gapping higher again this morning.
$0.2250 was resistance yesterday and has acted as support in the after-hours so that will be an important level to watch.
Above it, the first target for bulls will be the after-hours high of $0.2750. Beyond that, targets to the upside are $0.34, $0.4 and $0.5.
Below $0.2250 there is potential support at $0.1770, $0.1660, $0.1460, $0.1350 and then $0.1210.
ESPR - Trades 15% higher in premarket after Steve Cohen’s Point 72 Asset Management reports 5% passive stake in the company
Esperion Therapeutics (ESPR) disclosed that Point 72 Asset Management had taken a 5% passive stake in the company. Point 72 was founded by Steve Cohen and has assets under management of over $27 billion as of January 1 2023. Steve Cohen is a multi-billionaire himself.
ESPR has a market capitalization of only $117.52M according to Finviz based on yesterday’s close. It is unusual for such a large fund to take a stake in such a small company, but someone at Point 72 likes it. The stock was trading over $20 last year.
ESPR has found support around $1.40 so far in the pre-market so that will be an important level to watch.
Above that, the first target for bulls will be the after-hours high of $1.65. Beyond that, targets to the upside are $1.80, $2.16 and then a big gap to fill to $3.98.
Below $1.40, there is potential support at $1.33, and then a gap to fill at $1.26.
MCOM - Up over 20% as the company announces it has identified consistent imbalances and reported short interest, signaling the potential presence of illegal naked short sales
Micromobility.com (MCOM) made all-time lows yesterday after announcing that Share Intel's extensive analysis of MCOM stock has identified consistent imbalances and reported short interest, signaling the potential presence of illegal naked short sales. When compared to the average trading volume, these imbalances prove to be notably significant. The uncovered discrepancies may represent only the "tip of the iceberg," with the possibility of more extensive issues concealed within dark pools and ex-clearing activities.
The stock is gapping higher this morning in pre-market as traders digest the news.
The $2.50-$2.55 area has been support so far in the pre-market and will be an important level to watch.
Above it, targets to the upside are $2.80, $2.90, $3 and $3.18. Above that $4, $4.49 and a gap fill to $5.84 come into play.
Below $2.50 there is potential support at $2.40, a gap fill to $2.24 and then all-time lows at $2.21 for the stock.
Economic Calendar (EST)
7:30 am Challenger Job-cut report
8:30 am Jobless claims
10:00 am Fed Speaker James Bullard
10:30 am EIA Nat Gas report
1:00 pm Baker Hughes rig count
4:30 pm Fed balance sheet
Friday April 7th Market closed.
8:30 am Employment report
3:00 pm Consumer Credit
Earnings for Today (After Market)
APLD, CLIR, GHG, LEVI, EGY, WDFC
Earnings for Friday April 7th (full day)
GBX, IMBI, IDR, MTEM, OLB, PSMT, TIL, TLRY
Top Headlines
BOOM: DynaEnergetics Successfully Defends Itself in Patent Infringement Case
VALERO PORT ARTHUR completes crude unit overhaul, struggling to restart hydrotreater
ZIVO: ZIVO Bioscience Receives $1 Million Bridge Financing
VRE: Veris Residential Completes $420 Million Sale of Harborside 1, 2, and 3
ASNS: City of West Sacramento Modernizes Traffic Management With Actelis’ Hybrid Fiber-Copper Solutions
SAND: Sandstorm Gold Royalties Announces Record Sales and Revenue in First Quarter 2023 and Renews Normal Course Issuer Bid
TTCF: Tattooed Chef Receives Non-Compliance Notice from The Nasdaq Stock Market
HEDGE FUNDS MAKE $7BLN FROM BETTING AGAINST BANKS DURING TURMOIL – FT
VWE: Vintage Wine Estates Provides Preliminary Results of Fair Value Evaluation of Goodwill and Tradenames
AAL: American Airlines scraps traditional frequent flyer award chart in dynamic pricing shift – CNBC
LITE: Lumentum Announces Preliminary Financial Results and Reporting Date for Fiscal Third Quarter 2023, and Increased Share Repurchase Program
ERO: Ero Copper Demonstrates Significant Near-Term Growth in Updated 5-Year Outlook
DIS: Statement by Walt Disney Co.’s Largest Individual Shareholder Ike Perlmutter on Ending His Working Relationship with Company
SCLX: Scilex Holding Company Announces Postponement of Annual Meeting of Stockholders
AROW: Arrow Financial Corporation Announces Receipt of NASDAQ Noncompliance Notice
AMD: Samsung Electronics and AMD Extend Strategic IP Licensing Agreement to Bring AMD Radeon™ Graphics to Future Mobile Platforms
IDEX: Ideanomics' subsidiary Solectrac announces an exciting new addition to its lineup of top-selling e25 electric tractors
DNA: Sensible Biotechnologies Raises $4.2mn in a Pre-Seed Financing Round to Revolutionize mRNA Manufacturing
FAMI: Farmmi Shipping High-Volume Order of Healthy Dried Mushroom Slices to Customer for Sale in England
RVMD: Revolution Medicines to Present Preclinical Data at the Upcoming American Association for Cancer Research Annual Meeting 2023
GNS: Genius Group Commences Trading on Upstream Under the Ticker Symbol GNS
MITQ: Moving iMage Technologies Awarded Contract for New Flix Brewhouse Dine-In Cinema in Mansfield, Texas
ALDX: Aldeyra Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of ADX-629 in Atopic Dermatitis
ENTA: Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus
KXIN: Kaixin Auto Holdings Announces Joint New Energy Vehicle Export Trading Platform with China Vehicle Import and Export Corporation
SPIR: Leading Airline Industry Platform ch-aviation Selects Spire Global for a Long-Term Agreement to Provide Global Aircraft Fleet and Airline Operational Performance Insights
FSR: Fisker Completes All Applicable FMVSS Testing for Fisker Ocean SUV; Company Awaiting Official EPA Certification for US Range
VHAQ: Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market
IMGN: ImmunoGen Announces Non-Dilutive Term Loan Financing for Up to $175 Million with Pharmakon Advisors
TSLA: Tesla Teases Three New EVs Including Compact Car With 53-kWh LFP Pack – InsideEVs
COHR: Coherent Awarded Phase 2 of IARPA RESILIENCE Program for High-Energy Rechargeable Lithium-Sulfur Batteries
JFIN: Jiayin Group Inc. Announces Sales of Equity Interest in Fuzhou Zhuoqun Jieneng Information Technology Co., Ltd. and Fujian Jiaxi Financial Guarantee Co., Ltd.
NEO NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
VEEV: Veeva Pulse Reveals Digital Content More Than Twice as Effective in Driving Promotional Response
YOSH Yoshiharu Introduces New Restaurant Concept with Launch of Yoshiharu Ramen & Izakaya at its La Mirada Location
To Your Success!
Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions
*PAID ADVERTISEMENT. RagingBull has been paid twenty-two thousand five-hundred dollars by ach bank transfer by Awareness Consulting Group for advertising Mainz Biomed from a period beginning on April 3 , 2023 through April 6 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in Mainz Biomed. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Mainz Biomed, increased trading volume, and possibly an increased share price of the Mainz Biomed securities, which may or may not be temporary and decrease once the marketing arrangement has ended.
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.
SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct.
NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.
USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www. sec .gov/edgar/searchedgar/companysearch
TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.
WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https:// ragingbull. com/disclaimer.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
Reply